ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

Q: What does CUSIP H0036K147 represent in this 13F holders report?

CUSIP H0036K147 is the security identifier for ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share used to aggregate holder disclosures.

Q: How many institutions held ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in Q3 2024?

76 institutional investors reported ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share for Q3 2024. Use the holders table for investor-level position and value details.

CUSIP: H0036K147

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class: Equity / Common Shares, par value CHF 0.08 per share
Shares outstanding: 128,459,465
Total 13F shares: 54,883,537
Share change: +1,083,956
Total reported value: $172,881,709
Put/Call ratio: 38%
Price per share: $3.15
Number of holders: 76
Value change: +$3,394,419
Number of buys: 48
Number of sells: 24

Quarterly Holders Quick Answers

What is CUSIP H0036K147?
CUSIP H0036K147 identifies ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2024
Previous quarter: Q2 2024

Recent filing periods for CUSIP H0036K147:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Redmile Group, LLC	13F	Company	12%	15,269,217	$48,250,726	—	30 Jun 2024	13F
Prosight Management, LP	13F	Company	7.4%	9,570,000	$30,241,200	—	30 Jun 2024	13F
ORBIMED ADVISORS LLC	13F	Company	3.4%	4,316,824	$13,641,164	—	30 Jun 2024	13F
BlackRock Finance, Inc.	13F	Company	2.8%	3,554,742	$11,232,984	—	30 Jun 2024	13F
MORGAN STANLEY	13F	Company	2.3%	2,965,229	$9,370,123	—	30 Jun 2024	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	1,768,770	$5,589,313	—	30 Jun 2024	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.2%	1,524,717	$4,818,106	—	30 Jun 2024	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	1%	1,296,153	$4,095,843	—	30 Jun 2024	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.95%	1,216,418	$3,843,881	—	30 Jun 2024	13F
Artal Group S.A.	13F	Company	0.79%	1,018,461	$3,218,337	—	30 Jun 2024	13F
STATE STREET CORP	13F	Company	0.77%	991,296	$3,132,495	—	30 Jun 2024	13F
Vantage Consulting Group Inc	13F	Company	0.66%	850,737	$2,688,328	—	30 Jun 2024	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.64%	824,717	$2,606,104	—	30 Jun 2024	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.64%	816,456	$2,580,001	—	30 Jun 2024	13F
Blue Owl Capital Holdings LP	13F	Company	0.57%	733,568	$2,318,075	—	30 Jun 2024	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.53%	685,547	$2,166,329	—	30 Jun 2024	13F
Affinity Asset Advisors, LLC	13F	Company	0.37%	474,744	$1,500,191	—	30 Jun 2024	13F
GCM Grosvenor Holdings, LLC	13F	Company	0.32%	410,888	$1,298,406	—	30 Jun 2024	13F
VANGUARD GROUP INC	13F	Company	0.31%	404,229	$1,277,364	—	30 Jun 2024	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.26%	328,764	$1,038,894	—	30 Jun 2024	13F
Atom Investors LP	13F	Company	0.25%	322,289	$1,018,433	—	30 Jun 2024	13F
D. E. Shaw & Co., Inc.	13F	Company	0.21%	263,712	$833,330	—	30 Jun 2024	13F
Nuveen Asset Management, LLC	13F	Company	0.18%	237,304	$749,881	—	30 Jun 2024	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.18%	228,102	$720,802	—	30 Jun 2024	13F
Bank of New York Mellon Corp	13F	Company	0.16%	205,221	$648,498	—	30 Jun 2024	13F
DAFNA Capital Management LLC	13F	Company	0.16%	204,081	$644,896	—	30 Jun 2024	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.14%	175,462	$554,460	—	30 Jun 2024	13F
Florida Trust Wealth Management Co	13F	Company	0.09%	113,000	$357,080	—	30 Jun 2024	13F
RHUMBLINE ADVISERS	13F	Company	0.07%	85,977	$271,677	—	30 Jun 2024	13F
Composition Wealth, LLC	13F	Company	0.07%	84,496	$267,007	—	30 Jun 2024	13F
XTX Topco Ltd	13F	Company	0.04%	56,863	$179,687	—	30 Jun 2024	13F
Magnetar Financial LLC	13F	Company	0.04%	55,762	$176,208	—	30 Jun 2024	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.04%	54,126	$171,038	—	30 Jun 2024	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	41,433	$130,928	—	30 Jun 2024	13F
DEUTSCHE BANK AG\	13F	Company	0.03%	39,750	$125,610	—	30 Jun 2024	13F
Corebridge Financial, Inc.	13F	Company	0.03%	37,666	$119,401	—	30 Jun 2024	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.03%	36,076	$114,000	—	30 Jun 2024	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.03%	35,600	$112,496	—	30 Jun 2024	13F
BARCLAYS PLC	13F	Company	0.03%	33,849	$106,962	—	30 Jun 2024	13F
DLK Investment Management, LLC	13F	Company	0.03%	33,155	$104,770	—	30 Jun 2024	13F
Invesco Ltd.	13F	Company	0.03%	32,959	$104,150	—	30 Jun 2024	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.03%	32,600	$103,000	—	30 Jun 2024	13F
JPMORGAN CHASE & CO	13F	Company	0.02%	29,837	$94,285	—	30 Jun 2024	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.02%	26,938	$85,124	—	30 Jun 2024	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.02%	25,704	$81,225	—	30 Jun 2024	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	24,120	$76,219	—	30 Jun 2024	13F
NORTHERN TRUST CORP	13F	Company	0.02%	23,014	$72,724	—	30 Jun 2024	13F
Saxony Capital Management, LLC	13F	Company	0.02%	22,238	$70,272	—	30 Jun 2024	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.02%	22,020	$69,583	—	30 Jun 2024	13F
UBS Group AG	13F	Company	0.02%	21,193	$66,970	—	30 Jun 2024	13F

Institutional Holders of ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) as of Q3 2024

As of 30 Sep 2024, ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,883,537 shares. The largest 10 holders included Redmile Group, LLC, Prosight Management, LP, ORBIMED ADVISORS LLC, BlackRock, Inc., MORGAN STANLEY, BANK OF AMERICA CORP /DE/, SILVERARC CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, PLATINUM INVESTMENT MANAGEMENT LTD, and Siren, L.L.C.. This page lists 76 institutional shareholders reporting positions in this security for the Q3 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders

Q3 2024 holders

Holder diff

Investor	Q2 2024 Shares	Q3 2024 Shares	Share Diff	Share Chg %	Q2 2024 Value $	Q3 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.